BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 9153413)

  • 1. Altered sialylation of osteopontin prevents its receptor-mediated binding on the surface of oncogenically transformed tsB77 cells.
    Shanmugam V; Chackalaparampil I; Kundu GC; Mukherjee AB; Mukherjee BB
    Biochemistry; 1997 May; 36(19):5729-38. PubMed ID: 9153413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming JB6 cells exhibit enhanced integrin-mediated adhesion to osteopontin.
    Chang PL; Chambers AF
    J Cell Biochem; 2000 Apr; 78(1):8-23. PubMed ID: 10797562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of antisense osteopontin RNA inhibits tumor promoter-induced neoplastic transformation of mouse JB6 epidermal cells.
    Su L; Mukherjee AB; Mukherjee BB
    Oncogene; 1995 Jun; 10(11):2163-9. PubMed ID: 7784060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and characterization of recombinant osteopontin peptides representing matrix metalloproteinase proteolytic fragments.
    Gao YA; Agnihotri R; Vary CP; Liaw L
    Matrix Biol; 2004 Nov; 23(7):457-66. PubMed ID: 15579312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteopontin is synthesized by uterine glands and a 45-kDa cleavage fragment is localized at the uterine-placental interface throughout ovine pregnancy.
    Johnson GA; Burghardt RC; Joyce MM; Spencer TE; Bazer FW; Gray CA; Pfarrer C
    Biol Reprod; 2003 Jul; 69(1):92-8. PubMed ID: 12606367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of expression of osteopontin (OPN; secreted phosphoprotein) in metastatic, ras-transformed NIH 3T3 cells.
    Chambers AF; Behrend EI; Wilson SM; Denhardt DT
    Anticancer Res; 1992; 12(1):43-7. PubMed ID: 1567180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-V-dependent outside-in signaling is required for the regulation of CD44 surface expression, MMP-2 secretion, and cell migration by osteopontin in human melanoma cells.
    Samanna V; Wei H; Ego-Osuala D; Chellaiah MA
    Exp Cell Res; 2006 Jul; 312(12):2214-30. PubMed ID: 16631740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autocrine activation of an osteopontin-CD44-Rac pathway enhances invasion and transformation by H-RasV12.
    Teramoto H; Castellone MD; Malek RL; Letwin N; Frank B; Gutkind JS; Lee NH
    Oncogene; 2005 Jan; 24(3):489-501. PubMed ID: 15516973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 50-kDa membrane protein mediates sialic acid-independent binding and infection of conjunctival cells by adenovirus type 37.
    Wu E; Fernandez J; Fleck SK; Von Seggern DJ ; Huang S; Nemerow GR
    Virology; 2001 Jan; 279(1):78-89. PubMed ID: 11145891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic analysis and immunodetection of the bovine milk osteopontin isoforms.
    Bissonnette N; Dudemaine PL; Thibault C; Robitaille G
    J Dairy Sci; 2012 Feb; 95(2):567-79. PubMed ID: 22281321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteopontin induction is required for tumor promoter-induced transformation of preneoplastic mouse cells.
    Chang PL; Cao M; Hicks P
    Carcinogenesis; 2003 Nov; 24(11):1749-58. PubMed ID: 12919959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced malignancy of ras-transformed NIH 3T3 cells expressing antisense osteopontin RNA.
    Behrend EI; Craig AM; Wilson SM; Denhardt DT; Chambers AF
    Cancer Res; 1994 Feb; 54(3):832-7. PubMed ID: 8306346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteopontin modulates CD44-dependent chemotaxis of peritoneal macrophages through G-protein-coupled receptors: evidence of a role for an intracellular form of osteopontin.
    Zhu B; Suzuki K; Goldberg HA; Rittling SR; Denhardt DT; McCulloch CA; Sodek J
    J Cell Physiol; 2004 Jan; 198(1):155-67. PubMed ID: 14584055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adhesion of metastatic, ras-transformed NIH 3T3 cells to osteopontin, fibronectin, and laminin.
    Chambers AF; Hota C; Prince CW
    Cancer Res; 1993 Feb; 53(3):701-6. PubMed ID: 8425206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycosylation of the receptor guanylate cyclase C: role in ligand binding and catalytic activity.
    Ghanekar Y; Chandrashaker A; Tatu U; Visweswariah SS
    Biochem J; 2004 May; 379(Pt 3):653-63. PubMed ID: 14748740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive identification of post-translational modifications of rat bone osteopontin by mass spectrometry.
    Keykhosravani M; Doherty-Kirby A; Zhang C; Brewer D; Goldberg HA; Hunter GK; Lajoie G
    Biochemistry; 2005 May; 44(18):6990-7003. PubMed ID: 15865444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific reduction in osteopontin synthesis by antisense RNA inhibits the tumorigenicity of transformed Rat1 fibroblasts.
    Gardner HA; Berse B; Senger DR
    Oncogene; 1994 Aug; 9(8):2321-6. PubMed ID: 8036014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrin-linked kinase regulates osteopontin-dependent MMP-2 and uPA expression to convey metastatic function in murine mammary epithelial cancer cells.
    Mi Z; Guo H; Wai PY; Gao C; Kuo PC
    Carcinogenesis; 2006 Jun; 27(6):1134-45. PubMed ID: 16474180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal studies on the tissue compartmentalization of bone sialoprotein (BSP), osteopontin (OPN), and SPARC protein during bone formation in vitro.
    Kasugai S; Nagata T; Sodek J
    J Cell Physiol; 1992 Sep; 152(3):467-77. PubMed ID: 1510790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of Osteopontin in tumor metastasis.
    Wai PY; Kuo PC
    J Surg Res; 2004 Oct; 121(2):228-41. PubMed ID: 15501463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.